Vertika Kanaujia is Editor Audience Growth at Hindustan Times and oversees the website’s coverage of business news, health, technology and internet culture. She is a Chevening Scholar and a Columbia Journalism University Fellow. Vertika has been a journalist for more than 18 years. After starting her career as a business journalist in TV she has worked with various leading news channels. You can email her at email@example.com.
Articles by Vertika Kanaujia
Prince Harry at coronation, looked lonely with a fake smile, ignored by family
Prince Harry at King Charles III's coronation ceremony was a solemn sight of estrangement and loneliness
Published on May 07, 2023 04:17 PM IST
‘What if weakest US President is re-elected’, AI ad fuels fake news concerns
2024 US elections may witness a new battleground with artificial intelligence (AI) playing a key role in political advertising.
Published on Apr 26, 2023 10:56 PM IST
Unraveling the enigma of Satoshi Nakamoto, was he Steve Jobs? maybe not
On April 23, 2011, Bitcoin founder, Satoshi Nakamoto, disappeared. There are several theories and one links him to Steve Jobs, but there is no evidence.
Published on Apr 24, 2023 11:07 AM IST
AI song with fake ‘Drake’ and ‘The Weeknd’ vocals creates furore, pulled down
A fake artificial generated song of Drake’ and ‘The Weeknd’ has taken the world by surprise and the worst part is that it's very good and very fake.
Updated on Apr 20, 2023 04:05 PM IST
ChatGPT-4 is phenomenal but its ‘hallucinations’ make it flawed
OpenAI's GPT-4 has left researchers and academics stunned with its advanced capabilities in interpreting text and images to provide accurate responses to tricky questions. However, the technology's flaws cannot be ignored, including the potential for factual errors, harmful content, and spreading disinformation to suit its bias.
Updated on Mar 20, 2023 11:27 AM IST
How ChatGPT has triggered a Generative AI race between Google and Microsoft
Microsoft's ChatGPT and Google's Bard AI are battling it out for AI supremacy, with both facing bugs and criticism. Both companies have now launched improved versions of their products, while Google announced upcoming generative AI features GPT-4 promises advanced creativity but the battle raises concerns about the reliability of AI chatbots for widespread consumer adoption.
Updated on Mar 15, 2023 09:54 PM IST
AI is powering travel experience across the world: 10 examples
Artificial Intelligence is changing the way the world is travelling, read 10 innovative examples
Updated on Mar 04, 2023 02:06 PM IST
Make in Odisha Day 1 attracts investments worth ₹585,742 cr, 21 MoUs signed
Chief Minister, Naveen Patnaik, along with 54 corporate leaders today pitched for Odisha as a land of opportunity on the back of political stability, ease of doing business and transparency
Updated on Dec 01, 2022 09:20 PM IST
Naveen Patnaik bets big on Make in Odisha 3.0, eyes ₹6 lakh cr worth funds
Naveen Patnaik has inaugurated his states's big-ticket business conclave Make in Odisha
Updated on Nov 30, 2022 10:31 PM IST
UK visa delay: British High Commission apologises, gives options to travellers
In normal circumstances for non-settlement visa applications submitted outside the UK 90% are decided within 3 weeks; 98% within 6 weeks and 100% within 12 weeks of the application date. But this year the wait time has extended.
Published on Jun 13, 2022 11:37 PM IST
Understanding Belarus: Is it Putin's accomplice or a victim?
Exiled Belarusian opposition leader Sviatlana Tsikhanouskaya and other pro democracy protesters have accused President Alexandar Lukashenko of becoming a puppet government of Russia.
Published on Mar 31, 2022 02:50 PM IST
Karnataka Budget: Watch Shivakumar react to allocation for Mekedatu project
Karnataka Congress President DK Shivakumar said, “This is a reward for everyone who participated in our campaign. It is a victory for all of us and an example of how rights can be secured through collective struggle. Thanks to everyone who took part in the march.”
Updated on Mar 04, 2022 10:39 PM IST
Bengaluru India's top startup hub with a 34% leasing share
Delhi-NCR is amongst the fastest-growing market in terms of leasing by startupsMumbai has seen certain pockets of startup activity over the yearsStartups to lease 29 million sq ft space during 2022-24
Published on Feb 28, 2022 09:58 AM IST
Paytm IPO Opens: Should you buy or not? Here's expert advice
Expert advice on whether to invest your money in India's largest IPO, Paytm, which opens for subscriptions today
Updated on Nov 09, 2021 07:41 PM IST
Worried about Nykaa IPO share allotment? Here’s some advice for you
Retail investors are often left high and dry at the time of share allotment, considering most of the IPOs these days are getting oversubscribed. So how should one ride on the IPO craze and benefit from the excitement?
Updated on Nov 06, 2021 01:55 PM IST
Will the festive season trigger the third wave?
As we begin the festivities the most pertinent question being asked is, is the worst over for India and has Covid-19 now turned into an endemic, as being suggested by few experts or is it the lull before the storm?
Updated on Oct 13, 2021 07:47 PM IST
Coronavirus: Novel way to manage Diabetes amid Covid-19
As the world navigates these challenging times, India’s diabetes burden has taken on a new significance.
Updated on Jul 26, 2021 11:01 PM IST
ByVertika Kanaujia, Delhi
Zomato IPO: Why is there so much buzz and should you invest?
Food delivery giant Zomato’s IPO size is ₹9375 crore and public offer comprises a fresh issuance of equity shares of ₹9,000 crore.
Published on Jul 11, 2021 10:41 AM IST
ByVertika Kanaujia, Hindustan Times, New Delhi
Coronavirus | Post-Covid Stress Disorder: All you need to know
Dr Manu Tiwari, Consultant Psychiatrist at Noida's Fortis hospital shares his views on first identifying and then coping with post traumatic stress disorder among different age groups and professions.
Updated on Jul 09, 2021 10:19 PM IST
ByVertika Kanaujia, Hindustan Times, Delhi
Covid-19 antibody test not to be used to evaluate immunity, says doctor
Antibodies are proteinaceous substances made by our immune system to fight infections like viruses and may help to protect against future occurrences by those same infections.
Updated on Jul 01, 2021 10:50 PM IST
ByVertika Kanaujia | Edited by Shivani Kumar, Hindustan Times, New Delhi